Abstract
Purpose
To evaluate whether high LH/FSH ratio has a clinical impact on patients with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF) with GnRH-agonist/antagonist protocols or in vitro maturation (IVM) treatments.
Methods
We retrospectively reviewed all PCOS patients with day 3 LH/FSH ratio ≥1.5 who underwent IVF or IVM. The main outcomes measures were embryo quality and pregnancy rate.
Results
A total of 75 cycles were included. Among these, 44 patients underwent long agonist protocol, 16 antagonist protocol and 15 IVM. Age, basal LH and FSH levels, as well as duration of infertility were comparable for all groups. The LH level on the day of hCG administration was significantly lower in the antagonist group (0.9 IU/ml) compared to the long agonist group (1.4 IU/ml, p = 0.01). There was no difference in pregnancy rates among the groups: 27.2 % in the long agonist group, 37.5 % in the antagonist group and 26.6 % among the IVM patients.
Conclusions
High LH/FSH ratio had no adverse effect on pregnancy rates in all three treatment modes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome 2007, Thessaloniki, Greece. Fertil Steril 89:505–522
Taylor AE, McCourt B, Martin K et al (1997) Determinants of abnormal gonadotropin secretion in clinically defined women with PCOS. J Clin Endocrinol Metab 82:2248–2256
Waldstreicher J, Santoro NF, Hall HJE, Filicori M, Crowley WF (1988) Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence of partial gonadotroph desensitization. J Clin Endocrinol Metab 66:165–172
Tarlatzis BC, Grimbizis G, Pournaropoulos F, Bontis J, Spanos E, Mantalenakis S (1995) The prognostic value of basal LH:FSH ratio in the treatment of patients with PCOS by assisted reproduction. Hum Reprod 10:2545–2549
Balen AH, Tan SL, McDougall J, Jacobs HS (1993) Miscarriage rates following IVF are increased in women with PCO and reduced pituitary desensitization with buserelin. Hum Reprod 8:959–964
Gordon UD, Harrison RF, Hennelly B (2001) A randomized prospective assessor-blind evaluation of LH dosage and IVF. Fertil Steril 75:324–331
Mendoza C, Ruiz E, Ortega E et al (2002) Follicular fluid markers of oocyte developmental potential. Hum Reprod 17:1017–1022
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Rotterdam, The Netherlands (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25
Orvieto R, Meltcer S, Liberty G, Rabinson J, Anteby EY, Nahum R (2012) Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue? Gynecol Endocrinol 28:422–424
Wiser A, Shehata F, Holzer H, Hyman J, Shalom-Paz E, Son WY, Tulandi T (2013) Effect of high LH/FSH ratio on women with PCOS undergoing IVM treatment. J Reprod Med 58:1–5
Al-Inany HG, Youssef MAFM, Aboulghar M, Broekmans FJ, Sterrenburg MD, Smit JG et al (2011) Gonadotrophin releasing hormone antagonists for assisted reproductive technology. Cochrane Database of Systematic Reviews 5:CD001750
Choi MH, Lee SH, Kim HO et al (2012) Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: in vitro maturation, GnRH agonist, and GnRH antagonist cycles. Clin Exp Reprod Med 39:166–171
Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Devroey P, On Behalf of the Brussels GnRH Antagonist Consensus Workshop Group (2006) GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 12:333–340
Kolibianakis EM, Zikopoulos K, Schiettecatte J et al (2004) Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Hum Reprod 19:2490–2496
European and Middle East Orgalutran Study Group (2001) Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 16:644–651
Child TJ, Phillips SJ, Abdul-Jalil AK, Gulekli B, Tan SL (2002) A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries. Obstet Gynecol 100:665–670
Acknowledgments
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This research did not receive financial support.
Conflict of interest
The authors declare no conflicts of interest.
Ethical approval
The study was approved by the local Institutional Review Committee.
Informed consent
Due to the retrospective nature of the study, informed consent was waived.
Rights and permissions
About this article
Cite this article
Ganor-Paz, Y., Friedler-Mashiach, Y., Ghetler, Y. et al. What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation. J Endocrinol Invest 39, 799–803 (2016). https://doi.org/10.1007/s40618-015-0429-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-015-0429-x